Nov 08, 2024 / 01:30PM GMT
Operator
Good morning and welcome to Ocugen's third quarter, 2024 financial results and business update. Please note that this call is being recorded at this time. All participant lines are in listen-only mode following the speaker's commentary. There will be a question and answer session. I will now turn the call over to Tiffany J. Hamilton Ocugen's Head of Corporate Communications. You may begin.
Tiffany J. Hamilton - Ocugen Inc - Head of Corporate Communications
Thank you operator and good morning, everyone joining me on today's call and webcast is Dr. Shankar Musunuri, Ocugen's Chairman, CEO and Co-founder who will provide a business update and an overview of our clinical and operational progress. Ramesh Ramachandran, our Chief Accounting Officer who is transitioning from Michael Breininger. Interim Chief Accounting Officer is also on the call to provide a financial update for the quarter ended. September 30, 2024,
Dr. Huma Qamar, Chief Medical Officer and Dr. Arun Upadhyay, Chief Scientific Officer will be available to answer questions. Following the
Q3 2024 Ocugen Inc Earnings Call Transcript
Nov 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers